Fidelity International
ONCE

Fidelity International’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Fidelity International’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-93,057
Closed -$10.6M – 1008
2019
Q1 		$10.6M Sell
93,057
-6,308
-6% -$464K 0.02% 429
2018
Q4 		$3.89M Buy
99,365
+36,217
+57% +$1.57M 0.01% 532
2018
Q3 		$3.44M Sell
63,148
-13,069
-17% -$894K 0.01% 579
2018
Q2 		$6.31M Sell
76,217
-2,917
-4% -$225K 0.01% 532
2018
Q1 		$5.27M Sell
79,134
-8,084
-9% -$467K 0.01% 401
2017
Q4 		$4.49M Buy
87,218
+19,953
+30% +$1.43M 0.01% 419
2017
Q3 		$6M Buy
+67,265
New +$5.11M 0.02% 385
2015
Q3 		– Sell
-58,768
Closed -$3.54M – 550
2015
Q2 		$3.54M Buy
58,768
+7,533
+15% +$498K 0.01% 443
2015
Q1 		$3.97M Buy
+51,235
New +$2.95M 0.01% 424

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity International's ONCE Position: Q2 2019 in Review

Fidelity International sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 93,057 shares — an estimated $10.6M sold.

Fidelity International first reported a position in ONCE in Q1 2015 and held it in 9 quarters. The position peaked at $10.6M in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Fidelity International reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Fidelity International sold 93,057 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $10.6M.
  • Fidelity International first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • Fidelity International's Spark Therapeutics, Inc. Common Stock position peaked at $10.6M in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Fidelity International's 13F filing for Q2 2019, filed 13 Aug 2019.